Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
For a comprehensive overview of all TRIUMPH trials and retatrutide's development timeline, see our complete retatrutide guide
FDA Approval: Both Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound) are FDA-approved for diabetes and weight loss
J Intern Med, 2003
Holding the regimen can be complex or lead to errors
Carol Wysham reported on 978 patients with type 2 diabetes in the 52-week, phase III AWARD-1 trial who were randomized to dulaglutide at 1.5 or 0.75 mg, the injectable GLP-1 agonist exenatide at 10 mcg twice daily, or placebo
US$ 26.71
US$ 29.28
US$ 27.74
